Drug    DrugBank | All Description Patterns💬 Info on mouse-over

No.	Drug (Description in trials)	DrugBank	KEGG DRUG	KEGG GENES	KEGG PATHWAY On map, Yellow: Drug target genes	Disease ID
1	Bortezomib	Bortezomib	[1] D03150 💬	[1] PSMB5 💬	[8] Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia	[15] 11, 13, 26, 28, 46, 49, 51, 61, 63, 66, 228, 256, 283, 288, 331 💬
2	Bortezomib (velcade®)	Bortezomib	[1] D03150 💬	[1] PSMB5 💬	[8] Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia	[1] 66 💬
3	Bortezomib/dexamethasone	Bortezomib	[10] D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592, D03150 💬	[2] NR3C1, PSMB5 💬	[9] Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia	[1] 283 💬
4	Bortezomib/dexamethasone (bd), followed by autologous stc & maintenance bortezomib/dexamethasone	Bortezomib	[10] D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592, D03150 💬	[2] NR3C1, PSMB5 💬	[9] Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia	[1] 28 💬
5	Combination of a single dose anti-cd20 antibody and bortezomib	Bortezomib	[1] D03150 💬	[1] PSMB5 💬	[8] Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia	[1] 61 💬
6	Cyclophosphamide, bortezomib, and dexamethasone (cybord)	Bortezomib	[12] D00287, D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592, D03150, D07760 💬	[2] NR3C1, PSMB5 💬	[9] Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia	[1] 28 💬
7	Cyclophosphamide, bortezomib, dexamethasone	Bortezomib	[12] D00287, D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592, D03150, D07760 💬	[2] NR3C1, PSMB5 💬	[9] Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia	[1] 28 💬
8	Cyclophosphamide, bortezomib, dexamethasone plus daratumumab	Bortezomib	[13] D00287, D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592, D03150, D07760, D10777 💬	[3] CD38, NR3C1, PSMB5 💬	[16] Alzheimer disease, Amyotrophic lateral sclerosis, Calcium signaling pathway, Hematopoietic cell lineage, Huntington disease, Metabolic pathways, Neuroactive ligand-receptor interaction, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Salivary secretion, Spinocerebellar ataxia	[1] 28 💬